Tetra Bio-Pharma Inc. Completes Pre-IND Meeting with Food and Drug Administration on PPP001

OTTAWA, ONTARIO -- (Jan. 30, 2017) - PhytoPain Pharma Inc. ("PPP"), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain and other medical conditions announces that it has completed its pre-IND meeting with the USA Food and Drug Administration ("FDA") for its PPP001 dried cannabis drug product. The meeting was held in January 2017 with the Division of Anesthesia, Analgesia, and Addiction Products ("DAAAP"), Center for Drug Evaluation and Research ("CDER").
Read more: Tetra Bio-Pharma Inc ( TBP )

Valens GroWorks Licensing Inspection Completed

VANCOUVER, BRITISH COLUMBIA--(Jan. 13, 2017) -Valens GroWorks Corp. (CSE:VGW)(CSE:VGW.CN)(the "Company") is pleased to announce the completion, by the Regional Inspectorate of the Office of Controlled Substances of Health Canada, of their final inspection of wholly-owned subsidiary Valens Agritech's ("VAL") 17,000 square foot R&D facility located in Kelowna, British Columbia.
 
The inspection is the final stage required to achieve licensing under our application for a Controlled Drugs and Substances Dealer's Licence to enable the cultivation and processing of marijuana (such as creating extracts or derivatives) for the purpose of research, for processing manufacturing derivatives, and for transporting product to other locations (including related packaging, possession, sale, delivery and research activities).
Read more: Valens GroWorks Corp ( VGW )

SG Spirit Gold to Review Strategic Acquisition Opportunities

Enters Into Letter of Intent With Northern Lights Marijuana Company
 
VANCOUVER, BC--( January 03, 2017) - SG Spirit Gold Inc. (TSX VENTURE: SG) ("Spirit Gold" or the "Company") is pleased to announce that its board of directors has initiated a review of potential strategic acquisition opportunities for the Company, both within the resource sector and outside. To commence the review, the Company has signed a non-binding letter of intent (the "LOI") with Northern Lights Marijuana Company Limited ("Northern Lights") in order to evaluate the existing operations of Northern Lights with a view to pursuing an acquisition (the "Transaction").
Read more: SG Spirit Gold Inc ( SG )

Arcturus Signs Definitive Agreement to Acquire 15-Acres of Cannabis Zoned Land

Vancouver, British Columbia /  December 15, 2016 - Arcturus Growthstar Technologies Inc. (the "Company" or "Arcturus") (CSE: AGS) (OTCQB: AGSTF) is pleased to announce that it has signed a Definitive Agreement ("the Contract") to acquire a 15-acre parcel of land in Redland, Florida, in a county that is designated to legally cultivate, process and dispense cannabis. Redland is an unincorporated community within Miami-Dade County, with Biscayne National Park to the east and Everglades National Park to the west. Redland is a Miami suburb and a major agricultural area. Miami-Dade County is referred to as the nation's "Salad Bowl" and "Winter Bread Basket."
Read more: Arcturus Growthstar Technologies ( AGS )

Vinergy to acquire pot outfit, raise $2-million

Mr. Glen Macdonald reports
 
VINERGY RESOURCES LTD. ANNOUNCES LETTER AGREEMENT FOR ACQUISITION OF MJ BIOPHARMA (1099955 B.C. LTD.), A CANNABIS TECHNOLOGY COMPANY
 
Vinergy Resources Ltd. has signed a letter agreement dated Dec. 14, 2016, with an arm's-length private British Columbia company, pursuant to which the assignor has assigned to the company the rights and obligations of a letter agreement dated Dec. 13, 2016, between the assignor and MJ Biopharma (1099955 B.C. Ltd.), a private British Columbia company. Pursuant to the terms of the letter agreement, the company will acquire all of the issued and outstanding securities of MJ Biopharma.
Read more: Vinergy Resources Ltd ( VIN )

Videos / Webinars

View all videos

Pepperstone | Metatrader 4 Forex Broker